Approval · Notice of Compliance 9866 · 2008
MICARDIS PLUS: Notice of Compliance 9866
Issued October 30, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9866
- Date
- October 30, 2008
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 80 mg/25 mg
- Therapeutic class
- Angiotensin II at1 receptor blocker / diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICARDIS PLUS | 02318709 | Marketed |
Medicinal ingredients
- TELMISARTAN 80 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB